Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. (Q53633371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

M-C Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Y-B Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S Y Jung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

I H Chung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S-K Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

569-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Age at menopause as a risk factor for cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Effects of immunosuppressive drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1063OA

10.1191/0961203304LU1063OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15462485%20AND%20SRC:MED&resulttype=core&format=json

release_qt5b4drenfblrlsne4itkhw2oq

3 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qt5b4drenfblrlsne4itkhw2oq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference